Stock A175250 ICURE PHARMACEUTICAL INCORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Company Icure Pharmaceutical Incorporation

Equities

A175250

KR7175250000

Personal Products

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
1,915 KRW -0.36% Intraday chart for Icure Pharmaceutical Incorporation -1.39% -8.37%
Mar. 20 Icure Pharmaceutical Incorporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Icure Pharmaceutical Incorporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

Icure Pharmaceutical Incorporation is a Korea-based company mainly engaged in the production and sale of cosmetics. Along with subsidiaries, the Company operates its business through two segments. The Cosmetic segment is involved in the manufacturing and sale of cosmetics including basic cosmetics, mask packs, and patches. In addition, it is also engaged in the production and sale of body, hair care products and fragrances. The cosmetics are sold under the names of Botalinum, Mediheal N.M.F, Meditime, among others. The Pharmaceutical segment is engaged in the manufacturing and sale of over the counter (OTC) drugs, ethical the counter (ETC) drugs, as well as quasi drugs. The OTC drugs include anti-inflammatory analgesics and dementia treatments. The Company distributes its products within the domestic market and to overseas markets.

Number of employees: 199

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical
71.1 %
46,412 78.2 % 40,388 71.1 % -12.98%
Cosmetics
28.9 %
12,955 21.8 % 16,418 28.9 % +26.73%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
99.1 %
58,335 98.3 % 56,286 99.1 % -3.51%
Overseas
0.9 %
1,032 1.7 % 520 0.9 % -49.61%

Managers

Managers TitleAgeSince
Choi Young CEO
 Chief Executive Officer 64 -
Hyeon-Sik Jeong CTO
 Chief Tech/Sci/R&D Officer 62 -
Sang-Yoon Jeong BRD
 Director/Board Member 58 07-12-31
Young-Hoon Kook SAM
 Sales & Marketing 46 -
Sung-Wook Min AUD
 Comptroller/Controller/Auditor 49 -

Members of the board

Members of the board TitleAgeSince
Choi Young CEO
 Chief Executive Officer 64 -
Sang-Yoon Jeong BRD
 Director/Board Member 58 07-12-31
Hyeon-Sik Jeong CTO
 Chief Tech/Sci/R&D Officer 62 -
Yoon-Taek Jeong BRD
 Director/Board Member 55 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 37,558,368 31,708,922 ( 84.43 %) 188,683 ( 0.5024 %) 84.43 %

Shareholders

NameEquities%Valuation
Choi Young
13.60 %
5,106,880 13.60 % 8 M ₩
Korea Investment Partners Co., Ltd.
4.469 %
1,678,410 4.469 % 3 M ₩
Young-jin Choi
0.9729 %
365,392 0.9729 % 549 615 ₩
ICURE PHARMACEUTICAL INCORPORATION
0.5024 %
188,683 0.5024 % 283 813 ₩
Dong-hyun Choi
0.2372 %
89,103 0.2372 % 134 027 ₩
Dong-eun Choi
0.2372 %
89,103 0.2372 % 134 027 ₩
DFA Australia Ltd.
0.005487 %
2,061 0.005487 % 3 100 ₩
Chang Young
0.000000 %
0 0.000000 % - ₩

Holdings

NameEquities%Valuation
COSNINE CO., LTD.
3.19%
 2,760,000 3.19% 549,433 $
ICURE PHARMACEUTICAL INCORPORATION
0.50%
 188,683 0.50% 283,813 $

Company contact information

Icure Pharmaceutical Inc.

7th Floor, Donghwa Building 10 Bongeunsa-ro 104-gil

06170, Seoul

+

http://www.icure.co.kr
address Icure Pharmaceutical Incorporation(A175250)

Sector

Consumer Non-Cyclicals
Personal & Household Products & Services
Personal &Household Products & Services
Personal Products
Cosmetics & Perfumes

Sales per Business

Sales per region

Sector Cosmetics & Perfumes

1st Jan change Capi.
ICURE PHARMACEUTICAL INCORPORATION Stock Icure Pharmaceutical Incorporation
-8.37% 52.3M
L'ORÉAL Stock L'Oréal
-3.33% 250B
KAO CORPORATION Stock Kao Corporation
+10.09% 19.15B
GALDERMA GROUP AG Stock Galderma Group AG
0.00% 17.54B
SHISEIDO COMPANY, LIMITED Stock Shiseido Company, Limited
-1.32% 10.84B
COTY INC. Stock Coty Inc.
-7.73% 10.22B
AMOREPACIFIC CORPORATION Stock Amorepacific Corporation
+3.86% 6.53B
PROYA COSMETICS CO.,LTD. Stock Proya Cosmetics Co.,Ltd.
+9.76% 6B
NATURA &CO HOLDING S.A. Stock Natura &Co Holding S.A.
-0.06% 4.41B
INTER PARFUMS, INC. Stock Inter Parfums, Inc.
-16.98% 3.78B
Cosmetics & Perfumes
  1. Stock Market
  2. Equities
  3. A175250 Stock
  4. Company Icure Pharmaceutical Incorporation